98%
921
2 minutes
20
Objectives: While direct-to-consumer genetic tests are widely used in veterinary medicine, claims regarding communication and counselling issues have not been investigated so far. Our aim was to evaluate the communication channels encountered by clients when direct-to-consumer genetic tests are ordered, as well as access to genetic counselling to investigate whether these concerns are justified.
Materials And Methods: Checklists, email inquiries and direct-to-consumer genetic test kits were used to survey access to pre- and post-test counselling, as well as adherence to quality standards and guidelines of the website and test reports from 11 laboratories, spread across mainland Europe and the United Kingdom.
Results: Laboratories scored between 50% and 80% on a quality check of their websites using published standards. Prior to ordering genetic tests, counselling requests response rates were 69%, with most replies received within one business day. Genetic test report quality scores ranged between 67% and 78% for the administrative part and 67% to 100% for the test-related part. Seventy-five per cent of laboratories provided post-test counselling. Marked differences in genetic test recommendations were observed within and between laboratories for both Border Collies and Maine Coons, and this was not linked to geographical location, patents, or allele frequency.
Clinical Significance: The highly variable quality of websites and reports, access to counselling and recommendations on which genetic tests to use can have serious consequences for animal health and welfare. This substantiates the concerns expressed in the scarce veterinary literature.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jsap.70019 | DOI Listing |
J Small Anim Pract
August 2025
Center of Clinical Genetics for Companion Animals, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Objectives: While direct-to-consumer genetic tests are widely used in veterinary medicine, claims regarding communication and counselling issues have not been investigated so far. Our aim was to evaluate the communication channels encountered by clients when direct-to-consumer genetic tests are ordered, as well as access to genetic counselling to investigate whether these concerns are justified.
Materials And Methods: Checklists, email inquiries and direct-to-consumer genetic test kits were used to survey access to pre- and post-test counselling, as well as adherence to quality standards and guidelines of the website and test reports from 11 laboratories, spread across mainland Europe and the United Kingdom.
Nat Genet
August 2025
Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, UK.
Genetics
August 2025
Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089, United States.
In this perspective piece, we review the history of eugenics and its impacts on Indigenous peoples of North America. The perspective outlines historical policies, such as forced sterilization and immigration efforts targeting Indigenous populations. We explore how science is intertwined with eugenics and how eugenic ideologies continue to negatively impact Indigenous communities and science today.
View Article and Find Full Text PDFmedRxiv
July 2025
Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Introduction: Technological advances and direct-to-consumer marketing have unearthed significant organic demand from patients for cancer screening and prevention. However, in the absence of strong data or guidelines, physicians have minimal support on how to approach patients in clinical practice.
Methods: We projected individualized probabilities of 10-year and lifetime cancer risk across a population as well as potential improvement with healthy behaviors in the UK Biobank.
J R Soc N Z
October 2024
Carney Centre for Pharmacogenomics and Gene Structure and Function Laboratory, Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Pharmacogenetics is the study of genetic variants in genes which may impact on the outcome of drug treatment, either through safety considerations (occurrence of adverse drug reactions or therapeutic failure) or altered drug pharmacokinetics. This paper provides a brief history of pharmacogenetics research in the Aotearoa/New Zealand context, and a commentary on our current state. Factors that have limited translation of pharmacogenetic knowledge into ou r healthcare system are considered, and possible solutions to these are proposed.
View Article and Find Full Text PDF